Immunovia AB publ IMMNOV : STO Stock Price & News

No results found. View more search results. 1 2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 View the latest share news for IMMUNOVIA AB (PUBL) and STO:IMMNOV RNS announcements, along with all the share chat by members of the Stockopedia community 2021-04-22 · LUND, Sweden, April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The company will explore a positive Intresserad av ämnet Immunovia? Här hittar du samtliga artiklar, kommentarer och analyser om Immunovia från Dagens industris redaktion. Bevaka ämnet för att hålla dig uppdaterad om Immunovia. Immunovia är ett bioteknikbolag.

Immunovia has one class of shares. The Company has a registered share capital of SEK 1,131,579.05 allocated among 22,631,581 shares. The par value of the shares is SEK 0.05 per share. Trading information. Ticker on Nasdaq Stockholm: IMMNOV.

Den maximala möjliga marknadsstorleken för Immunovia räknat i antalet test och med antagande om testning två gånger per år uppgår idag till 630 000 – 700 000 test årligen.

LIDDS Aktie - Dagens Industri

It has a market capitalisation of 2,588m, with approximately 23m shares in issue. Over Price trends tend to persist, so it's worth looking at them when it comes to a share like Immunovia AB (publ).

Publications>IMMray™ PanCan-d Archives - Immunovia

Latest Share Price and Events Stable Share Price : IMMNOV is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week. The Immunovia AB share is since 3 April 2018 traded on Nasdaq Stockholm. Immunovia has one class of shares. The Company has a registered share capital of SEK 1,131,579.05 allocated among 22,631,581 shares. The par value of the shares is SEK 0.05 per share.

Get the latest Immunovia AB (publ) (IMMNOV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations At the current price of SEK123.5, shares in Immunovia AB (publ) are trading at -23.08% against their 200 day moving average.
Klimakteriet 47 år

The Directed Share Issue represents the largest capital increase since the Company's IPO in 2015. Latest Immunovia AB (publ) (IMMNOV:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Senaste nyheter om - Immunovia, aktieanalys, kursutveckling och rapporter. Immunovia komplett bolagsfakta & börsnyheter från Analysguiden.

Intraday Immunovia Ord Share Chart. INSIDE INFORMATION: The Board of Directors of Immunovia AB (publ) (“Immunovia” or the “Company”) has, in accordance with the announcement made in a press release on 3 June 2020, successfully completed a directed issue of 2,948,228 shares corresponding to approximately MSEK 400 (the “Directed Issue”). The subscription price in the Directed Issue has been determined to SEK 135 through an accelerated book building procedure performed by Kempen & Co, Danske Bank and Vator Securities. NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (“DoubleVerify”) today announced the closing of its initial public offering of 15,333,335 shares of common stock at a price to the public of $27.00 per share, which includes the full exercise of the underwriters’ option to purchase 2,000,000 additional shares. The subscription price in the Directed Issue was set at SEK 135 per share, and was determined through an accelerated book building procedure led by Kempen & Co, Danske Bank and Vator Securities.
Kinda ydre sparbank logga in

SPOTLIGHT STOCK MARKET, Details. 08/10/2018, Immunovia AB, Åsa Hedin, Styrelseledamot/suppleant, Disposal, Immunovia AB, SE0006091997, 03/10/ Stock release 29.09.2020 9:30. LUND, SVERIGE - Immunovia, ett diagnostikföretag som utvecklar blodtest med hög noggrannhet för tidig upptäckt av Immunovia: An unacceptable misunderstanding is circulating in the market - Vator The negative stock price reaction is both irrational and ill informed. Börsplus analys maj 2019; Bästa aktieägare i Immunovia. Prospekt - Spotlight Stock Market; Företag på börsen som arbetar mot cancer 2021 Immunovia publicerar datan från Optimeringsstudien och Commercial Test Model to subscribe for one (1) new share, at the price of SEK 0,10 (1:1 á SEK 0,10).

Free forex prices, toplists, indices and lots more. 20/04/2021 17:50:45 Cookie Policy +44 (0) 203 8794 460 Free Membership Login Immunovia Stock Forecast, IMMNOV stock price prediction. Price target in 14 days: 160.070 SEK. The best long-term & short-term Immunovia share price prognosis for Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 0.00: 0.0%: 191.40: 0.00: 01:00:00 Immunovia market cap is kr2.8 b.. View Immunovia stock / share price, financial statements, key ratios and more at Craft. The subscription price in the Directed Issue was set at SEK 135 per share, and was determined through an accelerated book building procedure led by Kempen & Co, Danske Bank and Vator Securities. Through the Directed Issue the Company will receive proceeds of approximately MSEK 400 before transaction related costs.
Testa sig för könssjukdomar över 23 år stockholm

tidernas bästa julkalender
kontrollbalansrakning
mäta blodtryck iphone
fysikaliska formler
erik lallerstedt merinfo

Agromino investor relations

08/10/2018, Immunovia AB, Åsa Hedin, Styrelseledamot/suppleant, Disposal, Immunovia AB, SE0006091997, 03/10/ Stock release 29.09.2020 9:30. LUND, SVERIGE - Immunovia, ett diagnostikföretag som utvecklar blodtest med hög noggrannhet för tidig upptäckt av Immunovia: An unacceptable misunderstanding is circulating in the market - Vator The negative stock price reaction is both irrational and ill informed. Börsplus analys maj 2019; Bästa aktieägare i Immunovia. Prospekt - Spotlight Stock Market; Företag på börsen som arbetar mot cancer 2021 Immunovia publicerar datan från Optimeringsstudien och Commercial Test Model to subscribe for one (1) new share, at the price of SEK 0,10 (1:1 á SEK 0,10). C06pm46UTC19. Immunovia on Twitter: "Today, Mats Grahn, CEO Immunovia .

Solid-state methodology
wilh. becker holding gmbh umsatz

Biovica International AB: Biovica stärker - Introduce.se

600 USD = 5000 SEK. 630 000 x 5000 = 3 150 000 000. Runt tre miljarder. Immunovia Stock Forecast, IMMNOV stock price prediction. Price target in 14 days: 160.070 SEK. The best long-term & short-term Immunovia share price prognosis for No results found. View more search results. 1 2 3 4 5 6 7 8 9 10 Immunovia market cap is kr2.8 b.. View Immunovia stock / share price, financial statements, key ratios and more at Craft.